Woudenberg F, Hijzen T H
Netherlands Institute for Drugs and Doping Research, Faculty of Pharmacy, University of Utrecht, The Netherlands.
Pharmacol Biochem Behav. 1991 Aug;39(4):859-63. doi: 10.1016/0091-3057(91)90044-3.
Discriminative stimulus effects have been studied extensively with the two-response, food-reinforced operant procedure and more recently also with discriminated taste aversion (DTA) procedures. DTA procedures have the advantage of a more rapid discrimination training. However, the test phase, i.e., drug substitution, of the DTA procedure is more time consuming (1 test per 4 days) than the test phase of the two-response procedure (2 tests per 5 days). The present study investigated whether a DTA procedure with 2 tests per 5 days could be implemented. In addition, the specificity of the DTA procedure was investigated. Rats were trained to discriminate chlordiazepoxide (CDP, 20 mg/kg, IP) from vehicle using a discriminated taste aversion procedure. Selective suppression of saccharin consumption after CDP injections was maximal after seven CDP-LiCl pairings. In subsequent substitution tests, with 2 tests per 5 days, CDP-mimicking effects were found only for another benzodiazepine, diazepam, and for a barbiturate, pentobarbital. The results indicate that rats can be rapidly trained to discriminate CDP from vehicle in the discriminated taste aversion procedure and that the CDP-cue so produced has the same specificity as in a two-response, food-reinforced operant procedure. However, the DTA procedure has a number of drawbacks that make its advantage over the two-response procedure questionable.
辨别性刺激效应已经在双反应、食物强化操作性程序中得到了广泛研究,最近也在辨别性味觉厌恶(DTA)程序中进行了研究。DTA程序具有辨别训练更快的优势。然而,DTA程序的测试阶段,即药物替代阶段,比双反应程序的测试阶段(每5天进行2次测试)更耗时(每4天进行1次测试)。本研究调查了是否可以实施每5天进行2次测试的DTA程序。此外,还研究了DTA程序的特异性。使用辨别性味觉厌恶程序训练大鼠区分氯氮卓(CDP,20mg/kg,腹腔注射)和溶剂。在7次CDP-氯化锂配对后,CDP注射后对糖精消耗的选择性抑制最大。在随后每5天进行2次测试的替代测试中,仅发现另一种苯二氮卓类药物地西泮和一种巴比妥类药物戊巴比妥具有CDP模拟效应。结果表明,在辨别性味觉厌恶程序中,大鼠可以快速训练以区分CDP和溶剂,并且如此产生的CDP线索与双反应、食物强化操作性程序中的具有相同的特异性。然而,DTA程序有许多缺点,这使得它相对于双反应程序的优势受到质疑。